patent/ZA-201807736-B

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_015145cfcc4ffcf7427d01ebf7f8345a
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
filingDate	2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7dd6f4824660f2e1e01645f497e1730 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e4c315ab652664a0011a9ade0c016a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb7c6d149c232b8f4c9aecfe641c6c93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125698db827a812a498a6922a2e6b7d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbb7ebf1653e32294983210c294ba52c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f3b7a5f05c1a97d69964e4c0542e2d4
publicationDate	2020-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	ZA-201807736-B
titleOfInvention	Use of nicotinic acid riboside or nicotinamide ribosite derivatives, and reduced derivatives thereof, as nad+increasing precursors
priorityDate	2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565323 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161233 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487363

Total number of triples: 21.